JP2008517918A5 - - Google Patents

Download PDF

Info

Publication number
JP2008517918A5
JP2008517918A5 JP2007538033A JP2007538033A JP2008517918A5 JP 2008517918 A5 JP2008517918 A5 JP 2008517918A5 JP 2007538033 A JP2007538033 A JP 2007538033A JP 2007538033 A JP2007538033 A JP 2007538033A JP 2008517918 A5 JP2008517918 A5 JP 2008517918A5
Authority
JP
Japan
Prior art keywords
seq
immunogenic composition
polypeptide
staphylococcus epidermidis
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007538033A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008517918A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/037746 external-priority patent/WO2007001423A2/en
Publication of JP2008517918A publication Critical patent/JP2008517918A/ja
Publication of JP2008517918A5 publication Critical patent/JP2008517918A5/ja
Pending legal-status Critical Current

Links

JP2007538033A 2004-10-21 2005-10-19 Ｓｔａｐｈｙｌｏｃｏｃｃｕｓｅｐｉｄｅｒｍｉｄｉｓポリペプチド抗原の免疫原性組成物 Pending JP2008517918A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62078804P 2004-10-21 2004-10-21
PCT/US2005/037746 WO2007001423A2 (en) 2004-10-21 2005-10-19 Immunogenic compositions of staphylococcus epidermidis polypeptide and polynucleotide antigens

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013021337A Division JP2013121981A (ja) 2004-10-21 2013-02-06 Ｓｔａｐｈｙｌｏｃｏｃｃｕｓｅｐｉｄｅｒｍｉｄｉｓポリペプチド抗原の免疫原性組成物

Publications (2)

Publication Number Publication Date
JP2008517918A JP2008517918A (ja) 2008-05-29
JP2008517918A5 true JP2008517918A5 (enExample) 2008-10-02

Family

ID=37595601

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007538033A Pending JP2008517918A (ja) 2004-10-21 2005-10-19 Ｓｔａｐｈｙｌｏｃｏｃｃｕｓｅｐｉｄｅｒｍｉｄｉｓポリペプチド抗原の免疫原性組成物
JP2013021337A Pending JP2013121981A (ja) 2004-10-21 2013-02-06 Ｓｔａｐｈｙｌｏｃｏｃｃｕｓｅｐｉｄｅｒｍｉｄｉｓポリペプチド抗原の免疫原性組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013021337A Pending JP2013121981A (ja) 2004-10-21 2013-02-06 Ｓｔａｐｈｙｌｏｃｏｃｃｕｓｅｐｉｄｅｒｍｉｄｉｓポリペプチド抗原の免疫原性組成物

Country Status (13)

Country Link
US (3) US8445000B2 (enExample)
EP (4) EP2340848A3 (enExample)
JP (2) JP2008517918A (enExample)
KR (1) KR20070068455A (enExample)
CN (1) CN101175508A (enExample)
AR (1) AR051826A1 (enExample)
AU (1) AU2005333603A1 (enExample)
BR (1) BRPI0516974A (enExample)
CA (1) CA2583121A1 (enExample)
IL (1) IL182546A0 (enExample)
TW (1) TW200619228A (enExample)
WO (1) WO2007001423A2 (enExample)
ZA (1) ZA200703274B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2468803B (en) * 2005-05-19 2011-01-19 Exocyte Ltd Screening methods for bacterial killing
WO2010119343A2 (en) * 2009-04-14 2010-10-21 Novartis Ag Compositions for immunising against staphylococcus aureus
JP5395264B2 (ja) 2009-06-22 2014-01-22 ワイス・エルエルシー 黄色ブドウ球菌（ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ）抗原の免疫原性組成物
US20110200995A1 (en) * 2009-09-04 2011-08-18 Intelligent Medical Devices, Inc. Optimized probes and primers and methods of using same for the detection, screening, isolation and sequencing of vancomycin resistance genes and vancomycin resistant enterococci
AU2012280904B2 (en) 2011-07-06 2017-02-23 Glaxosmithkline Biologicals S.A. Cationic oil-in-water emulsions
US9655845B2 (en) 2011-07-06 2017-05-23 Glaxosmithkline Biologicals, S.A. Oil-in-water emulsions that contain nucleic acids
WO2014033192A1 (en) * 2012-08-31 2014-03-06 Novartis Ag Stabilised proteins for immunising against staphylococcus aureus
ES2769647T3 (es) * 2014-03-26 2020-06-26 Glaxosmithkline Biologicals Sa Antígenos estafilocócicos mutantes
JP7181208B2 (ja) * 2016-10-21 2022-11-30 ソクプラ、サイエンシズ、エ、ジェニ、エス．イー．シー． ワクチン構築物およびブドウ球菌感染症に対するその使用
SG11202106340XA (en) * 2019-01-30 2021-07-29 Fujifilm Electronic Materials Usa Inc Container and method of preparing the same
KR102627009B1 (ko) * 2021-12-17 2024-01-19 (주)메디톡스 피부 유해 세균에 대한 항세균 활성을 갖는 세균 균주, 및 이를 포함하는 약제학적 조성물

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
US4837151A (en) 1980-05-19 1989-06-06 The Board Of Trustees Of The Leland Stanford Junior University, Stanford University Live vaccines comprising two mutations and foreign antigen
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5168062A (en) 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5078996A (en) 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
ATE141646T1 (de) 1986-04-09 1996-09-15 Genzyme Corp Genetisch transformierte tiere, die ein gewünschtes protein in milch absondern
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US4873316A (en) 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
IL101715A (en) 1991-05-02 2005-06-19 Amgen Inc Recombinant dna-derived cholera toxin subunit analogs
CA2123811C (en) * 1991-11-22 2005-07-05 Ali Ibrahim Fattom Type i and type ii surface antigens associated with staphylococcus epidermidis
US5769047A (en) 1991-12-23 1998-06-23 Zoche; Michael Engine with oil separator
EP1033135A1 (en) 1992-03-19 2000-09-06 Henry M. Jackson Foundation For The Advancement Of Military Medicine Broadly reactive opsonic antibodies that react with common staphyloccoccal antigens
US5593972A (en) 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
DE69434469T2 (de) * 1993-01-26 2006-06-14 Univ Pennsylvania Zusammensetzungen und verfahren zur verabreichung von genetischem material
US6995008B1 (en) * 1994-03-07 2006-02-07 Merck & Co., Inc. Coordinate in vivo gene expression
IL112820A0 (en) * 1994-03-07 1995-05-26 Merck & Co Inc Coordinate in vivo gene expression
US5571515A (en) 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
US5505947A (en) 1994-05-27 1996-04-09 The University Of North Carolina At Chapel Hill Attenuating mutations in Venezuelan Equine Encephalitis virus
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
JP4160633B2 (ja) * 1994-09-21 2008-10-01 ヘンリー エム．ジャクソン ファウンデーション フォー ザ アドバンスメント オブ ミリタリー メディスン 共通のブドウ球菌抗原と広範に反応するオプソニン作用性抗体
US5837533A (en) 1994-09-28 1998-11-17 American Home Products Corporation Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
US7153510B1 (en) 1995-05-04 2006-12-26 Yale University Recombinant vesiculoviruses and their uses
EP0857214A1 (en) * 1995-10-16 1998-08-12 Smithkline Beecham Plc Novel saliva binding protein
US6168918B1 (en) 1996-01-31 2001-01-02 American Home Products Corp. Method of detecting foreign DNA integrated in eukaryotic chromosomes
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US7060458B1 (en) * 1997-08-14 2006-06-13 Wyeth Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
US6380370B1 (en) * 1997-08-14 2002-04-30 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
WO2000012689A1 (en) * 1998-08-31 2000-03-09 The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin Polypeptides and polynucleotides from coagulase-negative staphylococci
PT1117435E (pt) 1998-09-30 2008-02-21 Us Gov Univ Health Sciences Holotoxina da cólera mutante como adjuvante
US6703492B1 (en) * 1999-11-09 2004-03-09 Smithkline Beecham Corporation Staphylococcus epidermidis nucleic acids and proteins
AU1478301A (en) 1999-11-09 2001-06-06 Glaxo Group Limited Staphylococcus epidermidis nucleic acids and proteins
GB0014907D0 (en) 2000-06-20 2000-08-09 Univ Sheffield Antigenic polypeptides
AT410798B (de) 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
US20020169288A1 (en) * 2001-03-15 2002-11-14 Magnus Hook Collagen-binding adhesin from staphylococcus epidermidis and method of use
BR0210216A (pt) 2001-06-07 2004-06-08 Wyeth Corp Holotoxina do cólera imunogênica, mutante (ct-crm), composição imunogênica, métodos para aumentar a resposta imune de um hospedeiro vertebrado a um antìgeno, e para produzir uma holotoxina do cólera imunogênica, mutante, sequência ou molécula de ácido nucleico isolado e purificado, célula hospedeira, e, uso de uma holotoxina do cólera mutante
CN1977971A (zh) 2001-06-07 2007-06-13 惠氏控股有限公司 作为佐剂的霍乱全毒素的突变体形式
EP1412379B1 (en) 2001-08-02 2012-01-25 The University Of Sheffield Vaccine
CN100351260C (zh) * 2002-11-12 2007-11-28 布赖汉姆妇女医院 葡萄球菌感染的多糖疫苗
CA2519511A1 (en) 2003-03-17 2004-09-30 Wyeth Holdings Corporation Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
US7628994B2 (en) 2003-03-31 2009-12-08 Intercell Ag S. epidermidis antigens
JP2008513406A (ja) 2004-09-22 2008-05-01 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 免疫原性組成物
CA2868867A1 (en) 2005-03-25 2006-09-28 National Research Council Of Canada Method of isolation of soluble polypeptides

Similar Documents

Publication Publication Date Title
JP5829830B2 (ja) Ｅ型肝炎ウイルスのポリペプチド断片、それを含むワクチン組成物及び診断キット、並びにその使用
JP5785080B2 (ja) 植物におけるワクチン及びモノクローナル抗体治療薬の高レベル迅速生産のためのｄｎａレプリコン系
JP2004512022A5 (enExample)
JPH07504565A (ja) ワクチンおよび診断に有用なＨｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉタンパク質
JP2006525330A5 (enExample)
JP2009022296A (ja) 髄膜炎菌種の細菌に特異的なｄｎａおよび蛋白質またはペプチド、それらの取得方法およびそれらの生物学的応用
JP2019537424A5 (enExample)
JP2002508394A (ja) 新規表面抗原
JP2008517918A5 (enExample)
RU2016133598A (ru) Композиция микобактериального антигена
JP2001521744A5 (enExample)
JP2010517544A5 (enExample)
EP2964032A1 (en) Compositions and methods for the production of virus-like particles
Santona et al. Mapping antigenic sites of an immunodominant surface lipoprotein of Mycoplasma agalactiae, AvgC, with the use of synthetic peptides
CN111500586B (zh) 特异结合狂犬病毒l蛋白加帽区的核酸适配体及其应用
US6808711B2 (en) Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines
JP2002512005A5 (enExample)
JP7230130B2 (ja) マイコプラズマ・ヒオリニス感染を予防治療する組成物及びその活性成分を生産するための発現ベクター及び方法
EP1654273A2 (en) Streptococcus pneumoniae knockout mutants
US20100068214A1 (en) Identification of Candidate Vaccine Antigens from Dichelobacter Nodosus
TWI606839B (zh) 防治豬鼻黴漿菌感染之組合物及生產該組合物的方法
AU750792B2 (en) 76 kDa, 32 kDa, and 50 kDa helicobacter polypeptides and corresponding polynucleotide molecules
WO2015039271A1 (zh) 蛋白a1g_01780在抗立氏立克次体的免疫保护中的应用
JP2008509659A5 (enExample)
AU783201B2 (en) DNA sequence encoding the specific antigen of salmonella typhi